No racial difference in allele frequencies of FCGR3A gene F158V polymorphisms in diffuse large B-cell lymphoma

被引：2
|
作者：
Hirakawa, Tsuneaki
Yamaguchi, Hiroki [1 ]
Mitamura, Yoshio [2 ]
Kosaka, Fumiko
Dan, Kazuo
Inokuchi, Koiti
机构：
[1] Nippon Med Sch, Dept Internal Med, Div Hematol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Sekino Clin Pharmacol Clin, Dept Internal Med, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 02期
关键词：
FC-GAMMA-RIIIA; NON-HODGKINS-LYMPHOMA; V/F POLYMORPHISM; PREDICT RESPONSE; RITUXIMAB; CHOP;
D O I：
10.1111/j.1600-0609.2010.01554.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [21] Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Griffiths, Robert
    Gleeson, Michelle
    Knopf, Kevin
    Danese, Mark
    BMC CANCER, 2010, 10
  • [22] MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma
    Hu, Li-Li
    Yu, Bingyun
    Yang, Jine
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1188 - 1193
  • [23] Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
    Yunfei Hu
    Ning Ding
    Xuan Jin
    Lixia Feng
    Lingyan Ping
    Yuqin Song
    Jun Zhu
    Cancer Cell International, 14
  • [24] Racial disparities in the incidence and survival outcomes in diffuse large B-cell lymphoma in adolescents and young adults
    Wasifuddin, Mustafa
    Ilerhunmwuwa, Nosakhare Paul
    Becerra, Henry
    Hakobyan, Narek
    Shrestha, Neharika
    Uche, Ifeanyi Nnamdi
    Lin, Htet
    Abowali, Hesham
    Zheng, Jin
    Yadav, Ruchi
    Pokhrel, Akriti
    Enayati, Ladan
    Hare, Mitchell
    Hehr, Rohan
    Kozii, Khrystyna
    Gibadullin, Bulat
    Avezbakiyev, Boris
    Wang, Jen-Chin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 454 - 459
  • [25] Prognostic value of interim 18F-FDG PET/CT in diffuse large B-cell lymphoma
    Ying, Zhitao
    Wang, Xuejuan
    Song, Yuqin
    Zheng, Wen
    Wang, Xiaopei
    Xie, Yan
    Lin, Ningjing
    Tu, Meifeng
    Ping, Lingyan
    Liu, Weiping
    Deng, Lijuan
    Zhang, Chen
    Yang, Zhi
    Zhu, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 95 - 101
  • [26] Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era
    Provencio, Mariano
    Martin, Paloma
    Garcia, Vanesa
    Candia, Antonio
    Sanchez, Antonio C.
    Bellas, Carmen
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2021 - 2030
  • [27] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Ankit Patel
    Niraj Bhatt
    S. S. Prakash
    Ghanashyam Biswas
    Rajnish Nagarkar
    Bodhisatta Roy
    Priyanka Samal
    Narendra Agrawal
    Sushil Meshram
    Ashish Kaushal
    C. T. Satheesh
    Ravikumar Wategaonkar
    Kasi Viswanathan Thiagarajan
    Kartikeya Jain
    P. Vijayaveeran
    Kalyan Mukherjee
    Kishore Singh
    Tushar Patil
    Amit Jain
    Tuphan Kanti Dolai
    Minish Jain
    Sachin Hingmire
    Tara Chand Gupta
    K. C. Lakshmaiah
    Deepan Rajamanickam
    Bhushan Nemade
    Vikash Goyal
    Pinaki Mahato
    Sanjeev Kumar Mendiratta
    Maulik Doshi
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 457 - 468
  • [28] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Patel, Ankit
    Bhatt, Niraj
    Prakash, S. S.
    Biswas, Ghanashyam
    Nagarkar, Rajnish
    Roy, Bodhisatta
    Samal, Priyanka
    Agrawal, Narendra
    Meshram, Sushil
    Kaushal, Ashish
    Satheesh, C. T.
    Wategaonkar, Ravikumar
    Thiagarajan, Kasi Viswanathan
    Jain, Kartikeya
    Vijayaveeran, P.
    Mukherjee, Kalyan
    Singh, Kishore
    Patil, Tushar
    Jain, Amit
    Dolai, Tuphan Kanti
    Jain, Minish
    Hingmire, Sachin
    Gupta, Tara Chand
    Lakshmaiah, K. C.
    Rajamanickam, Deepan
    Nemade, Bhushan
    Goyal, Vikash
    Mahato, Pinaki
    Mendiratta, Sanjeev Kumar
    Doshi, Maulik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (06) : 457 - 468
  • [29] The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab
    Ahlgrimm, Manfred
    Pfreundschuh, Michael
    Kreuz, Markus
    Regitz, Evi
    Preuss, Klaus-Dieter
    Bittenbring, Joerg
    BLOOD, 2011, 118 (17) : 4657 - 4662
  • [30] Exploratory Study on the Relationship Between FcγRIIIa Gene Polymorphisms and the Efficacy and Toxicity of Rituximab in the Treatment of Stage I/II Diffuse Large B-Cell Lymphoma
    Wuxiao, Zhijun
    Wang, Hua
    Su, Qunhao
    Zhou, Haiyan
    Hu, Min
    Tao, Shi
    Xu, Lu
    Chen, Yu
    Hao, Xinbao
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (05) : 615 - 622
12345